MedPath

The difference between the amount and the type of volatile organic compounds(VOCs) on exhaled breath of patients with cholangiocarcinoma and patients with benign biliary conditions

Phase 2
Recruiting
Conditions
CholangiocarcinomaBenign biliary conditions
&#45
Cancer screening
Cancer surveillance
Bile duct cancer
Diagnostic model
Biomarkers
Volatile organic compounds
Registration Number
TCTR20190907002
Lead Sponsor
Faculty of medicine, Chulalongkorn university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

- CCA and non-CCA patients with biliary conditions
- Age 18-80 years

Exclusion Criteria

- Patients with other cancers
- Patient with active biliary tract infection (< 4 weeeks)
- CCA patients who has been treated with chemotherapy or currently treat with chemotherapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To identify changes in the profile of VOCs in exhaled breath of patients with CCA compared to other 1 year exhaled breath
Secondary Outcome Measures
NameTimeMethod
a diagnostic model for CCA 1 year exhaled breath
© Copyright 2025. All Rights Reserved by MedPath